VAERS reports by lot

GSK Varicella/Shingles lot 9974P: VAERS reports

33 VAERS reports list lot 9974P as a GSK Varicella/Shingles vaccine, received between 2020-06-30 and 2022-06-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
6%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2628%
General / Systemic (non-local)1920%
Dermatological (non-injection-site)1516%
Neurological1415%
Musculoskeletal910%
Gastrointestinal66%
Cardiac / Cardiovascular22%
Allergic / Anaphylactic11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina5
Wisconsin3
California3
Maryland3
Florida3
Connecticut3
Pennsylvania2
Georgia2
Ohio2
Kansas1
South Dakota1
New Jersey1

Reports by month received

2020-061
2020-077
2020-085
2020-095
2020-102
2020-112
2020-123
2021-022
2021-031
2021-051
2021-082
2021-091
2022-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.